SPR Therapeutics featured on a NPR news story: A More Direct Way to Treat Pain is Being Developed in Cleveland.
A new electric nerve stimulation device for drug free joint pain relief is nearing FDA approval
Read the full article here
SPR’s Smartpatch Percutaneous PNS System Receives Australian Regulatory Approval
Smartpatch is the world’s first and only approved percutaneous PNS system for the treatment of chronic shoulder pain.
Read the full article (PDF)
SPR Therapeutics, in collaboration with Case Western Reserve University, NDI Medical, and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
Grant Awarded to Commercialize a Revolutionary Modular Neurostimulation System Designed to Address Neurological Conditions and Injuries
Read the full article here
SPR Therapeutics Receives CE Mark for Smartpatch PNS System
Neurodevice firm SPR Therapeutics has received the CE mark for its Smartpatch system, a peripheral nerve stimulation (PNS) therapy for the minimally-invasive treatment of pain.
Read the full article …
